Home » S.F. BIOTECH INKS $700M ALLIANCE
S.F. BIOTECH INKS $700M ALLIANCE
Sirna Therapeutics, which is pioneering a new class of therapeutics that turn off specific genes that underlie diseases, entered into an alliance worth as much as $700 million with GlaxoSmithKline to develop treatments for respiratory diseases. San Francisco Business Times (http://charlotte.bizjournals.com/sanfrancisco/stories/2006/04/10/story5.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May